4.63
price up icon4.04%   0.18
after-market Handel nachbörslich: 4.63
loading
Schlusskurs vom Vortag:
$4.45
Offen:
$4.45
24-Stunden-Volumen:
500.94K
Relative Volume:
0.54
Marktkapitalisierung:
$288.05M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-96.66M
KGV:
-2.1535
EPS:
-2.15
Netto-Cashflow:
$-83.73M
1W Leistung:
+5.95%
1M Leistung:
+3.81%
6M Leistung:
-19.48%
1J Leistung:
-57.99%
1-Tages-Spanne:
Value
$4.42
$4.64
1-Wochen-Bereich:
Value
$4.38
$4.70
52-Wochen-Spanne:
Value
$2.86
$16.62

Olema Pharmaceuticals Inc Stock (OLMA) Company Profile

Name
Firmenname
Olema Pharmaceuticals Inc
Name
Telefon
(415) 651-3316
Name
Adresse
780 BRANNAN STREET, SAN FRANCISCO
Name
Mitarbeiter
102
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-18
Name
Neueste SEC-Einreichungen
Name
OLMA's Discussions on Twitter

Vergleichen Sie OLMA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
OLMA
Olema Pharmaceuticals Inc
4.63 288.05M 0 -96.66M -83.73M -2.15
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
466.36 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.75 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
317.50 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
538.64 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.47 28.51B 3.81B -644.79M -669.77M -6.24

Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-04-02 Eingeleitet Goldman Buy
2024-01-30 Eingeleitet Citigroup Buy
2023-07-21 Eingeleitet Oppenheimer Outperform
2023-05-05 Eingeleitet CapitalOne Overweight
2023-02-22 Eingeleitet Credit Suisse Outperform
2022-07-06 Fortgesetzt Canaccord Genuity Buy
2022-06-09 Hochstufung H.C. Wainwright Neutral → Buy
2022-02-28 Eingeleitet H.C. Wainwright Neutral
2021-12-07 Fortgesetzt Cowen Outperform
2020-12-14 Eingeleitet Canaccord Genuity Buy
2020-12-14 Eingeleitet Cowen Outperform
2020-12-14 Eingeleitet JP Morgan Overweight
2020-12-14 Eingeleitet Jefferies Buy
Alle ansehen

Olema Pharmaceuticals Inc Aktie (OLMA) Neueste Nachrichten

pulisher
Jun 16, 2025

Deeper Dive: Understanding Olema Pharmaceuticals Inc (OLMA) Through its Various Ratios - DWinneX

Jun 16, 2025
pulisher
Jun 13, 2025

Olema Pharmaceuticals Holds Annual Stockholders Meeting - TipRanks

Jun 13, 2025
pulisher
Jun 12, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Jun 12, 2025
pulisher
Jun 10, 2025

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Globe and Mail

Jun 10, 2025
pulisher
Jun 10, 2025

Two Sigma Investments LP Has $425,000 Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Jun 10, 2025
pulisher
Jun 07, 2025

Squarepoint Ops LLC Grows Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Jun 07, 2025
pulisher
Jun 07, 2025

HC Wainwright Issues Pessimistic Outlook for OLMA Earnings - MarketBeat

Jun 07, 2025
pulisher
Jun 07, 2025

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Acquired by Wellington Management Group LLP - MarketBeat

Jun 07, 2025
pulisher
Jun 05, 2025

Jane Street Group LLC Trims Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

Q2 EPS Forecast for Olema Pharmaceuticals Lowered by Analyst - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Sold by Two Sigma Advisers LP - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

ProShare Advisors LLC Purchases 3,298 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Ru - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Olema Oncology Expands Team with 322,000 Share Options Grant to New Biotech Talent - Stock Titan

Jun 03, 2025
pulisher
Jun 02, 2025

Deutsche Bank AG Increases Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Jun 02, 2025
pulisher
Jun 01, 2025

Bank of America Corp DE Has $5.05 Million Stake in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

Jun 01, 2025
pulisher
Jun 01, 2025

Millennium Management LLC Acquires 901,159 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

Jun 01, 2025
pulisher
May 31, 2025

H.C. Wainwright Backs Olema Pharmaceuticals (OLMA) as Phase 3 Trials Advance - MSN

May 31, 2025
pulisher
May 29, 2025

H.C. Wainwright maintains Buy on Olema Pharma, $28 target By Investing.com - Investing.com UK

May 29, 2025
pulisher
May 29, 2025

D. E. Shaw & Co. Inc. Cuts Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

May 29, 2025
pulisher
May 29, 2025

Ameriprise Financial Inc. Has $2.62 Million Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

May 29, 2025
pulisher
May 28, 2025

Olema Pharmaceuticals, Inc. Announces Palazestrant Dose Selection and Trial-In-Progress Poster at ASCO 2025 Annual Meeting - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

Olema Pharmaceuticals (OLMA) Aligns with FDA on Key Dosage for Trials | OLMA Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Olema Oncology Announces Palazestrant Dose Selection and Trial-in-Progress Poster at ASCO 2025 Annual Meeting - GlobeNewswire

May 28, 2025
pulisher
May 28, 2025

FDA Green Lights Crucial Dose for Olema's Advanced Breast Cancer Drug with 2027 Launch Target - Stock Titan

May 28, 2025
pulisher
May 28, 2025

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Purchased by Millennium Management LLC - Defense World

May 28, 2025
pulisher
May 28, 2025

Bank of America Corp DE Increases Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

May 28, 2025
pulisher
May 25, 2025

Northern Trust Corp Buys 34,053 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

May 25, 2025
pulisher
May 23, 2025

BNP Paribas Financial Markets Makes New $1.13 Million Investment in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

May 23, 2025
pulisher
May 22, 2025

Wall Street Analysts See a 386.42% Upside in Olema Pharmaceuticals (OLMA): Can the Stock Really Move This High? - MSN

May 22, 2025
pulisher
May 22, 2025

Olema Oncology to Participate in Upcoming Investor Conferences - The Manila Times

May 22, 2025
pulisher
May 21, 2025

Olema Oncology Advances Cancer Trials with Strong Financials - TipRanks

May 21, 2025
pulisher
May 21, 2025

Olema Oncology to Participate in Upcoming Investor Conferences | - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Olema Oncology to Participate in Upcoming Investor Conferences | OLMA Stock News - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Breast Cancer Biotech Olema Sets Major Presentations at Goldman Sachs and Jefferies Healthcare Conferences - Stock Titan

May 21, 2025
pulisher
May 19, 2025

Paradigm Biocapital Advisors LP Purchases 1,801,370 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

May 19, 2025
pulisher
May 19, 2025

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Bought by MPM Bioimpact LLC - MarketBeat

May 19, 2025
pulisher
May 18, 2025

Price T Rowe Associates Inc. MD Has $153,000 Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

May 18, 2025
pulisher
May 17, 2025

The Goldman Sachs Group Cuts Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $18.00 - Defense World

May 17, 2025
pulisher
May 17, 2025

Oppenheimer Cuts Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $22.00 - Defense World

May 17, 2025
pulisher
May 17, 2025

Q2 EPS Estimate for Olema Pharmaceuticals Raised by Analyst - Defense World

May 17, 2025
pulisher
May 16, 2025

Voya Investment Management LLC Cuts Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

May 16, 2025
pulisher
May 16, 2025

Driehaus Capital Management LLC Invests $1.28 Million in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

May 16, 2025
pulisher
May 15, 2025

Analysts Offer Insights on Healthcare Companies: Astria Therapeutics (ATXS), Aquestive Therapeutics (AQST) and Olema Pharmaceuticals (OLMA) - The Globe and Mail

May 15, 2025
pulisher
May 15, 2025

Companies Like Olema Pharmaceuticals (NASDAQ:OLMA) Are In A Position To Invest In Growth - Yahoo Finance

May 15, 2025
pulisher
May 15, 2025

Olema Pharmaceuticals (OLMA) Price Target Lowered by Oppenheimer - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Balyasny Asset Management L.P. Increases Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

May 15, 2025
pulisher
May 14, 2025

Olema Pharmaceuticals (OLMA) Price Target Lowered by Goldman Sachs | OLMA Stock News - GuruFocus

May 14, 2025

Finanzdaten der Olema Pharmaceuticals Inc-Aktie (OLMA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Olema Pharmaceuticals Inc-Aktie (OLMA) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Graham G. Walmsley
Director
Dec 17 '24
Sale
6.75
700,761
4,730,137
0
Zojwalla Naseem
CHIEF MEDICAL OFFICER
Dec 16 '24
Option Exercise
4.87
14,000
68,180
129,509
$21.25
price up icon 3.56%
$35.51
price down icon 0.22%
$22.99
price up icon 1.68%
$96.14
price down icon 0.84%
$111.66
price up icon 1.46%
biotechnology ONC
$244.47
price up icon 1.44%
Kapitalisierung:     |  Volumen (24h):